Luis Peña, Evommune CEO
After getting their candidates back from Eli Lilly, the old Dermira team is dashing for the clinic
After getting bought out by Eli Lilly for $1 billion last year, the old Dermira team regrouped in January with their own upstart and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
